Sawgrass Asset Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Sawgrass Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 23, 2019	SELL	$18.92 - $22.96 $1.2 Million - $1.46 Million	-63,600 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$19.46 - $25.28 $1.01 Million - $1.31 Million	51,890 Added 443.13%	63,600 $1.3 Million
Q4 2018 Feb 01, 2019	BUY	$17.72 - $22.51 $207,501 - $263,592	11,710 New	11,710 $233,000

287

35.1M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.18B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sawgrass Asset Management LLC with notifications on news.